KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $698.4 million.

  • Exact Sciences' Operating Expenses fell 4907.66% to $698.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 billion, marking a year-over-year decrease of 1705.18%. This contributed to the annual value of $2.5 billion for FY2025, which is 1705.18% down from last year.
  • Exact Sciences' Operating Expenses amounted to $698.4 million in Q4 2025, which was down 4907.66% from $609.5 million recorded in Q3 2025.
  • Exact Sciences' 5-year Operating Expenses high stood at $1.4 billion for Q4 2024, and its period low was -$16.4 million during Q4 2023.
  • Over the past 5 years, Exact Sciences' median Operating Expenses value was $613.9 million (recorded in 2021), while the average stood at $599.3 million.
  • In the last 5 years, Exact Sciences' Operating Expenses tumbled by 25631.42% in 2023 and then surged by 844354.54% in 2024.
  • Quarter analysis of 5 years shows Exact Sciences' Operating Expenses stood at $555.0 million in 2021, then plummeted by 98.11% to $10.5 million in 2022, then plummeted by 256.31% to -$16.4 million in 2023, then skyrocketed by 8443.55% to $1.4 billion in 2024, then crashed by 49.08% to $698.4 million in 2025.
  • Its last three reported values are $698.4 million in Q4 2025, $609.5 million for Q3 2025, and $564.6 million during Q2 2025.